GSK Investigational Site
Böblingen, Baden-Wurttemberg 71034
0 studies enrolling now · 1 studies all time
What they study most
Alzheimer's Disease
Studies at this site
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
— Completed